Endocan to Predict Cardiovascular Events: A Promising Biomarker or a Coincidental Finding?

Akboga, Mehmet Kadri; Gokaslan, Serkan; Balci, Kevser Gulcihan; Yayla, Çagri; Demirtas, Koray

Akboga, Mehmet Kadri; Gokaslan, Serkan; Balci, Kevser Gulcihan; Yayla, Çagri; Demirtas, Koray.

Afiliação

Akboga MK; Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey mkakboga@yahoo.com.
Gokaslan S; Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.
Balci KG; Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.
Yayla Ç; Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.
Demirtas K; Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.

Angiology ; 68(1): 84, 2017 01.

Article em En | MEDLINE | ID: mdl-27381031

Assuntos

Biomarcadores; Mortalidade Hospitalar; Humanos; Infarto do Miocárdio; Proteínas de Neoplasias; Proteoglicanas

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Mortalidade Hospitalar Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Angiology Ano de publicação: 2017 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links